Leishmaniasis in humans: drug or vaccine therapy?

M Ghorbani, R Farhoudi - Drug design, development and therapy, 2017 - Taylor & Francis
Leishmania is an obligate intracellular pathogen that invades phagocytic host cells.
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …

Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy

R Velez, M Gállego - Tropical Medicine & International Health, 2020 - Wiley Online Library
Canine leishmaniosis is an important vector‐borne zoonosis caused mainly by Leishmania
infantum. Diagnosis and treatment of affected individuals can be particularly complex …

[图书][B] Georgi. Parasitología para veterinarios

DD Bowman - 2022 - books.google.com
El libro de texto de veterinaria más completo y fiable para el diagnóstico y el tratamiento de
las infecciones parasitarias. Exhaustiva obra de referencia con información actualizada …

The prevention of canine leishmaniasis and its impact on public health

D Otranto, F Dantas-Torres - Trends in parasitology, 2013 - cell.com
Canine leishmaniasis (CanL) caused by Leishmania infantum is a vector-borne disease of
great veterinary and medical significance. Prevention of CanL requires a combined …

Saponins from Quillaja saponaria and Quillaja brasiliensis: Particular Chemical Characteristics and Biological Activities

JD Fleck, AH Betti, FP Da Silva, EA Troian, C Olivaro… - Molecules, 2019 - mdpi.com
Quillaja saponaria Molina represents the main source of saponins for industrial applications.
Q. saponaria triterpenoids have been studied for more than four decades and their …

One Health: the global challenge of epidemic and endemic leishmaniasis

CB Palatnik-de-Sousa, MJ Day - Parasites & vectors, 2011 - Springer
Abstract'One Health'proposes the unification of medical and veterinary sciences with the
establishment of collaborative ventures in clinical care, surveillance and control of cross …

Vaccine candidates for leishmaniasis: a review

R Nagill, S Kaur - International immunopharmacology, 2011 - Elsevier
Leishmaniasis is a diverse group of clinical syndromes caused by protozoan parasites of the
genus Leishmania. The clinical manifestation of the disease varies from self-limiting …

Biomarkers Associated With Leishmania infantum Exposure, Infection, and Disease in Dogs

C Maia, L Campino - Frontiers in cellular and infection microbiology, 2018 - frontiersin.org
Canine leishmaniosis (CanL) is a vector-borne disease caused by the protozoan
Leishmania (Leishmania) infantum species [syn. L.(L.) infantum chagasi species in the …

Immunological perspectives of leishmaniasis

S Nylén, S Gautam - Journal of global infectious diseases, 2010 - journals.lww.com
Leishmania parasites have been widely used in experimental models to understand
generation, maintenance and failure of immune responses underlying resistance and …

[HTML][HTML] Vaccination in leishmaniasis: a review article

L Abdellahi, F Iraji, A Mahmoudabadi… - Iranian Biomedical …, 2022 - ncbi.nlm.nih.gov
Leishmaniasis is caused by protozoan Leishmania parasites that are transmitted through
female sandfly bites. The disease is predominantly endemic to the tropics and semi-tropics …